U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

THIS PAGE IS TEMPORARILY UNDER CONSTRUCTION WHILE ENHANCEMENTS ARE UNDERWAY. Drug shortage data continues to be updated while under construction.

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Ketorolac Tromethamine Injection
Status: Currently in Shortage
»Date first posted: 03/23/2018
»Therapeutic Categories: Analgesia/Addiction

Expand all

Alembic Pharmaceuticals (Revised 08/14/2023)

Company Contact Information:
908-393-9604

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25) Product available
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 62332-600-25) Product available
Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25) Product available

Baxter Healthcare (Revised 09/27/2023)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10) Limited Supply; Recovery: May 2024 Demand increase for the drug
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25) Limited supply; Recovery: June 2024 FOR INTRAVENOUS AND INTRAMUSCULAR USE. 30mg/mL (1 mL fill volume/ 2 mL container) Demand increase for the drug

Fresenius Kabi USA (Revised 09/01/2023)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10) Backordered. Next release not available at this time. Check wholesaler for inventory. Demand increase for the drug
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10) Available Check wholesaler for inventory. Demand increase for the drug
Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20) Available Check wholesaler for inventory Demand increase for the drug
Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01) Backordered. Next release September 2023. Check wholesaler for inventory Demand increase for the drug
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01) Backordered. Next release September 2023. Check wholesaler for inventory. Demand increase for the drug
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02) Backordered. Next release September 2023. Check wholesaler for inventory. Demand increase for the drug

Gland Pharma Limited (Revised 06/08/2023)

Company Contact Information:
855-273-0154

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 70860-700-01) Available Demand increase for the drug
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 70860-701-01) Available Demand increase for the drug
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 70860-701-02) Available Demand increase for the drug
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 70860-701-03) Available Demand increase for the drug
Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 70860-700-02) Available Demand increase for the drug
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 70860-701-04) Available Demand increase for the drug
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25) Available Demand increase for the drug
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25) Available Demand increase for the drug

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Reverified 05/16/2023)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25) Unavailable, shortage recovery TBD. Demand increase for the drug
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25) Unavailable, shortage recovery TBD. Demand increase for the drug
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25) Unavailable, shortage recovery TBD. Demand increase for the drug

Hospira, Inc. (Reverified 09/11/2023)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01) Depleted Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Demand increase for the drug
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01) Depleted Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Demand increase for the drug
Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 0409-3796-01) Depleted Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Demand increase for the drug

Sagent Pharmaceuticals (Revised 09/14/2023)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01) In stock under NDC 70860-70-002 - 25021-700-01 due week of 9/19/23 Demand increase for the drug
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) In stock under NDC 70860-70-004 -25021-701-02 due week of 9/19/23 Demand increase for the drug
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) Backordered. Delivery expected mid-September 2023 Demand increase for the drug
Back to Top